MIT

Researchers from the Singapore-MIT Alliance for Research and Technology has adapted a novel electrostatic microfilter to enhance detection of low concentrations of pathogens.

With $8 million in seed funding, Droplet is developing a test for minimal residual disease detection in head and neck cancer, with research ongoing for other promising targets.

The paper-based assay detects the presence of neutralizing antibodies in the blood and can return results in 10 minutes.